(Q62035320)
Statements
A 12-week, Randomized, Double-blind, Placebo-controlled, Parallel-group Clinical Study to Evaluate the Efficacy and Safety of Trehalose in Patients With Fatty Liver Disease (English)
0 references
30 June 2016
0 references
20 March 2018
0 references
39
0 references
19 year
0 references
79 year
0 references